BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12220833)

  • 1. Chitosan and its derivatives--a promising non-viral vector for gene transfection.
    Guang Liu W; De Yao K
    J Control Release; 2002 Sep; 83(1):1-11. PubMed ID: 12220833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy.
    Mansouri S; Lavigne P; Corsi K; Benderdour M; Beaumont E; Fernandes JC
    Eur J Pharm Biopharm; 2004 Jan; 57(1):1-8. PubMed ID: 14729076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient gene delivery by urocanic acid-modified chitosan.
    Kim TH; Ihm JE; Choi YJ; Nah JW; Cho CS
    J Control Release; 2003 Dec; 93(3):389-402. PubMed ID: 14644588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability.
    Erbacher P; Zou S; Bettinger T; Steffan AM; Remy JS
    Pharm Res; 1998 Sep; 15(9):1332-9. PubMed ID: 9755882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-based gastrointestinal delivery systems.
    Hejazi R; Amiji M
    J Control Release; 2003 Apr; 89(2):151-65. PubMed ID: 12711440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosans for gene delivery.
    Borchard G
    Adv Drug Deliv Rev; 2001 Nov; 52(2):145-50. PubMed ID: 11718938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro gene delivery mediated by chitosan. effect of pH, serum, and molecular mass of chitosan on the transfection efficiency.
    Sato T; Ishii T; Okahata Y
    Biomaterials; 2001 Aug; 22(15):2075-80. PubMed ID: 11432586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and prospects of chitosan and its derivatives as non-viral gene vectors in gene therapy.
    Tong H; Qin S; Fernandes JC; Li L; Dai K; Zhang X
    Curr Gene Ther; 2009 Dec; 9(6):495-502. PubMed ID: 19807649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting.
    Gao S; Chen J; Xu X; Ding Z; Yang YH; Hua Z; Zhang J
    Int J Pharm; 2003 Apr; 255(1-2):57-68. PubMed ID: 12672602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of cationic polymer vector for gene delivery systems].
    Chen JH
    Yao Xue Xue Bao; 2003 Apr; 38(4):316-20. PubMed ID: 12889137
    [No Abstract]   [Full Text] [Related]  

  • 11. The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy.
    Miller AD
    Curr Med Chem; 2003 Jul; 10(14):1195-211. PubMed ID: 12678794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes.
    Aral C; Akbuga J
    J Pharm Pharm Sci; 2003; 6(3):321-6. PubMed ID: 14738712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification.
    Agirre M; Zarate J; Puras G; Ojeda E; Pedraz JL
    Drug Deliv; 2015 Jan; 22(1):100-10. PubMed ID: 24471693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic lipid vectors for plasmid DNA delivery.
    Hirko A; Tang F; Hughes JA
    Curr Med Chem; 2003 Jul; 10(14):1185-93. PubMed ID: 12678793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery.
    Lee M; Nah JW; Kwon Y; Koh JJ; Ko KS; Kim SW
    Pharm Res; 2001 Apr; 18(4):427-31. PubMed ID: 11451027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharide gene transfection agents.
    Khan W; Hosseinkhani H; Ickowicz D; Hong PD; Yu DS; Domb AJ
    Acta Biomater; 2012 Dec; 8(12):4224-32. PubMed ID: 23022542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles.
    Corsi K; Chellat F; Yahia L; Fernandes JC
    Biomaterials; 2003 Mar; 24(7):1255-64. PubMed ID: 12527266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic lipids in gene delivery: principles, vector design and therapeutical applications.
    Ilies MA; Seitz WA; Balaban AT
    Curr Pharm Des; 2002; 8(27):2441-73. PubMed ID: 12369942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible bidirectional shRNA expression vector delivery using PEI/chitosan-TBA copolymers for colorectal Cancer gene therapy.
    Javan B; Atyabi F; Shahbazi M
    Life Sci; 2018 Jun; 202():140-151. PubMed ID: 29656061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of chitosan in gene therapy: Developments and challenges.
    Dong L; Li Y; Cong H; Yu B; Shen Y
    Carbohydr Polym; 2024 Jan; 324():121562. PubMed ID: 37985064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.